网络研讨会

观看网络研讨会 - 19 七月 2022

Evolution of cell & gene therapy in China: the case for universal CAR-T

China now represents 60% of clinical development in CAR-T therapy development globally: what have we learned to date and where are future opportunities?

观看网络研讨会 - 07 六月 2022

Accelerating clinical development in China & the US

China and the US are the world’s largest oncology research destinations, and the clinical research bridge between them supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.

观看网络研讨会 - 20 五月 2022

Development and Regulatory Strategy for US and China

This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers. Additionally, it aims to understand the Evolving U.S. regulatory requirements for diversity in clinical cancer trials.

观看网络研讨会 - 13 五月 2022

Go/No Go Decisions Based on Early Phase Oncology Trials

Understanding the latest regulatory and clinical developments in the field of Oncology in China, along with discussing the similarities and differences between Chinese oncology market and the overall global market, promote academic exchange and cooperation of the global oncology research and development ecosystem.

观看网络研讨会 - 22 十月 2021

Driving efficiencies through virtual trial solutions in Asia Pacific

What is driving the acceleration of clinical trials in the Asia Pacific region and what are key considerations to maximise the opportunity for decentralised clinical trials in the future across the region.

观看网络研讨会 - 13 九月 2021

Accelerating Clinical Trials in Rare Disease - Understanding Asia’s success as a rare disease clinical trial location

This webinar looks at Asia’s rare disease clinical trial landscape, why China is an increasingly attractive location for rare disease trials and critical program strategies to consider.

观看网络研讨会 - 14 七月 2021

Expedited clinical development strategies for China

A two-part webinar interview and panel discussion with exclusive insights into China’s regulatory environment, the advantages of involving China sites, and strategies to accelerate entry in China.

观看网络研讨会 - 26 三月 2021

Presented By Katrina Norial at OCT Southeast

亚太地区：加速临床试验项目的解决方案

由 Katrina Norial 在 OCT Southeast 上发表。在此演讲中， Katrina Norial 讨论了 Novotech 的能力，如何确保 COVID-19 期间临床试验的连续性，以及如何利用区域优势加速临床试验开发。

观看网络研讨会 - 21 三月 2021

The benefits of running clinical trials in China

在中国进行临床试验大有裨益

中国为生物技术公司提供了加快临床开发的重要机会。在本简报中，我们将讨论：
在中国开展生物技术临床试验的最新研究和趋势, 与美国相比，监管要求有何差别？生物技术公司在中国设立研究中心有什么优势？,申办方和研究人员的反馈

观看网络研讨会 - 18 十二月 2020

Achieving regulatory milestones & meeting commercial goals

实现监管里程碑和达成商业目标

获得行业专家对产品开发规划和法规事务领域的独家见解，以了解精简而集中的全球计划战略的重要性。

观看网络研讨会 - 23 十月 2020

Managing Global Studies with Regional Partners

In this webinar, you'll learn about 1) Working with specialist CRO partners to maintain speed, flexibility, “fit” and regional expertise, 2) Leveraging technology and gold standard systems to provide integrated global management structure and reporting and 3) Advantages and tradeoffs of different global clinical trial setups.

观看网络研讨会 - 25 九月 2020

Accelerating Clinical Trials in Australia and Asia

澳大利亚和亚洲的加速临床试验——STEVEN ROAN在美国OCT的演讲

Steven Roan剖析了澳大利亚和亚洲的加速临床试验。演讲分为三个主要部分。介绍Novotech和亚太地区如何应对新冠肺炎流行病；Novotech在这些时期将采取什么措施为各公司提供支持；最后谈论在亚太地区开展临床试验工作的优势

联系

招贤纳士

解决方案

资源

关于

Location Settings

Asia-Pacific

North America

GLOBAL

Location Settings

Asia-Pacific

North America